How to stop Pfizer’s faux-Irish tax ripoff

The U.S. Treasury is going after inversions, but drug companies’ vulnerability is Medicare, says Tim Mullaney.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.